SABPA Medical Device and Diagnostics Forum

As China surpasses Japan as the world’s second-largest economy, and while China’s central government invests $193 billion to modernize China’s healthcare system, a tremendous market is emerging for medical devices and diagnostics. Johnson & Johnson, Medtronic, and other industry behemoths from the U.S. and Europe are stepping up their presence in China to capitalize on the $14 billion medical device market, which is expected to double by 2014. SABPA, the Sino-American Biomedical and Pharmaceutical Professionals Association, has organized this conference as an opportunity for a diverse cross-section of companies to share their successes and the challenges they faced navigating the Chinese market. More information and registration is available online here.